Asia-Pacific Americas Africa Europe Middle East

TOBIO NOVELFARMA ILAC

Company Profile:

Company Type: Manufacturer (Factory)

Company Introduction:

Location: Turkey

Industry: Pharmaceutical Industry

Overview:

TOBIO NOVELFARMA ILAC is a Turkish pharmaceutical company primarily focused on the manufacturing, research and development, import, export, and marketing of a diverse range of pharmaceutical products. Their product portfolio typically encompasses human medicines, veterinary medicines, medical devices, cosmetics, and food supplements.

The company aims to contribute to public health and well-being by providing innovative, high-quality, and reliable healthcare solutions. They are involved in various stages of the pharmaceutical lifecycle, from product development and production to distribution and sales in both domestic and international markets.

Enterprise Products

TOBIO NOVELFARMA ILAC company in Turkey manufactures or sells the following products:

ALERGOX (Desloratadine, antihistamine)

NEOFLU (Fluticasone Propionate, nasal corticosteroid)

NEOFLUFORT (Fluticasone Propionate, higher strength nasal corticosteroid)

SEFAPROX (Cefprozil, antibiotic)

TOBLOX (Levofloxacin, antibiotic)

TOBIMAX (Tobramycin, ophthalmic antibiotic)

TOBIMAX K (Tobramycin and Dexamethasone, ophthalmic antibiotic and corticosteroid)

ROXIN (Roxithromycin, antibiotic)

TOBIFLU (Oseltamivir, antiviral)

SEFASPOR (Cefixime, antibiotic)

KLAROMAX (Clarithromycin, antibiotic)

CIPROXIN (Ciprofloxacin, antibiotic)

LEVOPRAX (Levofloxacin, antibiotic)

LEVOKSIN (Levofloxacin, antibiotic)

UROVEX (Nitrofurantoin, urinary tract antibiotic)

MUCOVITAL (Erdosteine, mucolytic)

DEFLAZ (Deflazacort, corticosteroid)

Business Registration Information:

Manager:

Dr. Ali Yücel (Chairman of the Board)

Phone:

+90 216 680 08 08

E-mail:

info@novelfarma.com.tr

Official Website:
Address:

Kavacık Mah. Ekinciler Cad. No:11 Kavacık Beykoz / İstanbul, Turkey

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.